On February 12, 2025, Biolog, a leading provider of cell-based microbial and phenotypic profiling products and multiomic microbial identification services, announced the acquisition of Anaerobe Systems. The acquisition will be funded through a financing led by J.P. Morgan Life Sciences Private Capital with participation from existing investors BroadOak Capital Partners and Research Corporation Technologies. Wilson Sonsini Goodrich & Rosati advised Anaerobe Systems on the transaction.

Anaerobe Systems offers the most effective chambers and media for anaerobic research, along with a team that possesses deep knowledge of the behavior and functioning of anaerobic bacteria. With the acquisition, Biolog will expand its product offerings for clinical microbiology, microbiome research, and agricultural markets.

The Wilson Sonsini team that advised Anaerobe Systems on the transaction includes:

Corporate
Brian Appel
Victor MacDiarmid
Laura Jetter
Dana Hall
Eaton Liu

Technology Transactions
Ian Edvalson
Shefali Tandon Lumb

Patents and Innovations
Ali Alemozafar
Jane Chen

Tax
Myra Sutanto Shen
Anjali Krishnan

Real Estate
Susan Reinstra

Employee Benefits and Compensation
Michael Klippert
Peg Friel

FDA Regulatory
Eva Yin

For more information, please see Biolog and Anaerobe Systems’ joint news release.